August 27, 2009

TGaS Advisors Named to 2009 INC 500/5000, Ranked First in Business Products & Services in the Mid-Atlantic Region

TGaS® Advisors, the leader in benchmark and advisory services for pharmaceutical commercial organizations, has been recognized for the second year in a row as one of the fastest-growing private companies in the United States by Inc. Magazine in its 2009 rankings.

TGaS Advisors ranks first in Business Products & Services and 11th overall in the Mid-Atlantic region (PA-NJ-DE-MD). The company also placed in the top 50 nationwide for Business Products & Services, and was ranked #522 in overall national listings. Despite the difficult economic climate, TGaS Advisors achieved a three-year growth rate of more than 500 percent, introducing new benchmarks in Commercial Compliance, Integration Services and Sales Leadership, adding to its client roster and providing deeper services to existing clients. The company has added staff, including the recent appointment of Anthony Sorce as Vice President for New Business Development.

Managing Partner Stephen E. Gerard attributes TGaS Advisors' growth to the firm’s experienced leadership, collaborative relationship with clients and the flexibility to grow as clients require more strategic services. According to Gerard, "TGaS Advisors' achievements arise from our unique concept of working as Trusted Advisors from the 'outside-in,' creating a community of pharmaceutical executives and providing confidential fact-based answers to the question, 'How do other pharmaceutical companies do "it"?'®"

Most TGaS Advisors associates are 20-year industry veterans, coming to the firm from such companies as Wyeth, Roche Pharmaceuticals, Schering-Plough, King Pharmaceuticals, Abbott Laboratories, Yamanouchi (Astellas), Thomson Reuters, IMS Health and SimStar (Rosetta Interactive). Senior advisors communicate findings exclusively to peer-set participants, providing insights specific to each client and addressing strategy, tactics and optimal practices based on results and industry experience.

The Inc. 5000 is ranked according to percentage revenue growth from 2005 through 2008. To qualify, companies must be U.S.-based, privately held, for profit and independent – not subsidiaries or divisions of other companies – as of December 31, 2008. Revenue in 2005 must have been at least $200,000, and revenue in 2008 must have been at least $2 million. The top 10 percent of companies on the list comprise the Inc. 500, now in its 28th year. (www.inc.com)

About TGaS® Advisors

TGaS Advisors, ranked in the top 50 among U.S. Business Products & Services companies by the Inc. 500, is the leader in benchmarking and advisory services to the pharmaceutical and biopharmaceutical industry. The TGaS Advisors roster includes nine of the top 10 and the majority of the top 50 pharmaceutical companies with operations in the U.S. market. The firm's benchmarking and advisory services suite of solutions, PharmaStance®, provides clients with a way to measure where they stand with respect to their organizations and answers the question, "How do other pharmaceutical companies do 'it'?"®, TGaS Advisors is based in East Norriton, Pennsylvania.